Sernova Biotherapeutics (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2015 | 10-2014 | 10-2013 | 10-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 171 | 426 | 269 | N/A |
| Marketable Securities | 2,151 | 2,711 | 4,614 | N/A |
| Receivables | 177 | 105 | 50 | N/A |
| TOTAL | $2,518 | $3,280 | $5,061 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 24 | 14 | 19 | N/A |
| Intangibles | 0 | 398 | 1,046 | 0 |
| TOTAL | $24 | $411 | $1,065 | $N/A |
| Total Assets | $2,541 | $3,691 | $6,126 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 161 | 220 | 221 | 0 |
| TOTAL | $161 | $220 | $221 | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $161 | $220 | $221 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 23,039 | 24,512 | 25,820 | N/A |
| Retained earnings | -23,897 | -24,597 | -23,596 | N/A |
| Other shareholders' equity | 754 | 848 | 913 | 0 |
| TOTAL | $2,380 | $3,471 | $5,906 | $N/A |
| Total Liabilities And Equity | $2,541 | $3,691 | $6,126 | $0 |